Chitosan-based silver nanoparticles: A study of the antibacterial, antileishmanial and cytotoxic effects

Journal of Bioactive and Compatible Polymers

Volumn 32, Issue 4, 2017, Pages 397-410

  Lima, Douglas Dos Santos ^a   Gullon, Beatriz ^b,c   Cardelle Cobas, Alejandra ^b   Brito, Lucas M ^a   Rodrigues, Klinger A F ^a   Quelemes, Patrick V ^a   Ramos Jesus, Joilson ^a   Arcanjo, Daniel D R ^a   Plácido, Alexandra ^d   Batziou, Krystallenia ^e   Quaresma, Pedro ^e   Eaton, Peter ^e   Delerue Matos, Cristina ^d   Carvalho, Fernando Aecio A ^a   Da Silva, Durcilene Alves ^a   Pintado, Manuela ^b   Leite, Jose Roberto De S A ^a,e,f  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b CBQF CENTRO DE BIOTECNOLOGIA E QUÍMICA FINA LABORATÓRIO ASSOCIADO   (Portugal)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d INSTITUTO SUPERIOR DE ENGENHARIA DO PORTO   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

^f UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Antibacterial activity; antileishmanial activity; chitosan; cytotoxicity; Leishmania; MTT; resazurin; silver nanoparticles

Indexed keywords

ASSAYS; ATOMIC FORCE MICROSCOPY; CHITIN; CHITOSAN; CYTOTOXICITY; METAL NANOPARTICLES; NANOPARTICLES; SYNTHESIS (CHEMICAL); TRANSMISSION ELECTRON MICROSCOPY;

ANTI-BACTERIAL ACTIVITY; FOURIER TRANSFORM INFRA REDS; LEISHMANIA; MICROBIAL INFECTIONS; MINIMUM INHIBITORY CONCENTRATION; RESAZURIN; SILVER NANOPARTICLES; SODIUM BORO HYDRIDES;

SILVER;

CHITOSAN; SILVER NANOPARTICLE; SILVER NITRATE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; COLORIMETRY; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; INFRARED SPECTROSCOPY; LEISHMANIA AMAZONENSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; ZETA POTENTIAL;

EID: 85024486348     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911516681329     Document Type: Article

References (53)

1. Ravi Kumar MN,. A review of chitin and chitosan applications. React Funct Polym 2000; 46: 1-27.
2. Illum L,. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998; 15: 1326-1331.
3. Stulzer HK, Lacerda L, Tagliari MP, et al. Synthesis and characterization of cross-linked malonylchitosan microspheres for controlled release of acyclovir. Carbohydr Polym 2008; 73: 490-497.
4. Alves NM, Mano JF,. Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications. Int J Biol Macromol 2008; 43: 401-414.
5. Bhattacharya R, Mukerjee P,. Biological properties of "naked" metal nanoparticles. Adv Drug Deliv Rev 2008; 60: 1289-1306.
6. Choi S-J, Oh J-M, Choy J-H,. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J Inorg Biochem 2009; 103: 463-471.
7. Durán N, Durán M, de Jesus MB, et al. Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity. Nanomedicine 2016; 12: 789-799.
8. I coordination polymer: a new precursor for preparation of silver nanoparticles. Inorganica Chim Acta 2009; 362: 1035-1041.
9. Qadan M, Cheadle WG,. Common microbial pathogens in surgical practice. Surg Clin North Am 2009; 89: 295-310.
10. Wei D, Sun W, Qian W, et al. The synthesis of chitosan-based silver nanoparticles and their antibacterial activity. Carbohydr Res 2009; 344: 2375-2382.
11. Venkatesham M, Ayodhya D, Madhusudhan A, et al. A novel green one-step synthesis of silver nanoparticles using chitosan: catalytic activity and antimicrobial studies. Appl Nanosci 2014; 4: 113-119.
12. Khameneh B, Diab R, Ghazvini K, et al. Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them. Microb Pathog 2016; 95: 32-42.
13. Nadhman A, Nazir S, Khan MI, et al. PEGylated silver doped zinc oxide nanoparticles as novel photosensitizers for photodynamic therapy against. Leishmania. Free Radic Biol Med 2014; 77: 230-238.
14. Abamor ES, Allahverdiyev AM,. A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles-Nigella sativa oil combinations. Exp Parasitol 2016; 166: 150-163.
15. Sundar S, Singh A, Singh OP,. Strategies to overcome antileishmanial drugs unresponsiveness. J Trop Med 2014; 2014: 646932.
16. Quelemes PV, Araruna FB, de Faria BEF, et al. Development and antibacterial activity of cashew gum-based silver nanoparticles. Int J Mol Sci 2013; 14: 4969-4981.
17. Carneiro SMP, Carvalho FAA, Santana LCLR, et al. The cytotoxic and antileishmanial activity of extracts and fractions of leaves and fruits of Azadirachta indica (A Juss.). Biol Res 2012; 45: 111-116.
18. O'Brien J, Wilson I, Orton T, et al. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000; 267: 5421-5426.
19. Rolón M, Vega C, Escario JA, et al. Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes. Parasitol Res 2006; 99: 103-107.
20. Esmaeili J, Mohebali M, Edrissian GH, et al. Evaluation of miltefosine against Leishmania major (MRHO/IR/75/ER): in vitro and in vivo studies. Acta Med Iran 2008; 46: 191-196.
21. Qi L, Xu Z, Jiang X, et al. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 2004; 339: 2693-2700.
22. Murugadoss A, Chattopadhyay A,. A "green" chitosan-silver nanoparticle composite as a heterogeneous as well as micro-heterogeneous catalyst. Nanotechnology 2008; 19: 015603.
23. Pavinatto FJ, Pavinatto A, Caseli L, et al. Interaction of chitosan with cell membrane models at the air-water interface. Biomacromolecules 2007; 8: 1633-1640.
24. Hafdani FN, Sadeghinia N,. A review on application of chitosan as a natural antimicrobial. Int J Med Heal Biomed Bioeng Pharm Eng 2011; 5: 46-50.
25. Muzzarelli R, Tarsi R, Filippini O, et al. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob Agents Chemother 1990; 34: 2019-2023.
26. Rhoades J, Roller S,. Antimicrobial actions of degraded and native chitosan against spoilage organisms in laboratory media and foods. Appl Environ Microbiol 2000; 66: 80-86.
27. Jeon Y-J, Park P-J, Kim S-K,. Antimicrobial effect of chitooligosaccharides produced by bioreactor. Carbohydr Polym 2001; 44: 71-76.
28. Raafat D, Sahl H-G,. Chitosan and its antimicrobial potential-a critical literature survey. Microb Biotechnol 2009; 2: 186-201.
29. No HK, Young Park N, Ho Lee S, et al. Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int J Food Microbiol 2002; 74: 65-72.
30. Sashiwa H, Aiba S,. Chemically modified chitin and chitosan as biomaterials. Prog Polym Sci 2004; 29: 887-908.
31. Tarsi R, Muzzarelli RAA, Guzman CA, et al. Inhibition of Streptococcus mutans adsorption to hydroxyapatite by low-molecular-weight chitosans. J Dent Res 1997; 76: 665-672.
32. Liu XF, Guan YL, Yang DZ, et al. Antibacterial action of chitosan and carboxymethylated chitosan. J Appl Polym Sci 2001; 79: 1324-1335.
33. Rabea EI, Badawy ME-T, Stevens CV, et al. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003; 4: 1457-1465.
34. Je J-Y, Kim S-K,. Chitosan derivatives killed bacteria by disrupting the outer and inner membrane. J Agric Food Chem 2006; 54: 6629-6633.
35. Prabhu S, Poulose EK,. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int Nano Lett 2012; 2: 32.
36. Danilczuk M, Lund A, Sadlo J, et al. Conduction electron spin resonance of small silver particles. Spectrochim Acta A Mol Biomol Spectrosc 2006; 63: 189-191.
37. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007; 3: 95-101.
38. Feng QL, Wu J, Chen GQ, et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and. Staphylococcus aureus. J Biomed Mater Res 2000; 52: 662-668.
39. Matsumura Y, Yoshikata K, Kunisaki S, et al. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol 2003; 69: 4278-4281.
40. Mori Y, Ono T, Miyahira Y, et al. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res Lett 2013; 8: 93.
41. Nguyen VQ, Ishihara M, Mori Y, et al. Preparation of size-controlled silver nanoparticles and chitin-based composites and their antimicrobial activities. J Nanomater 2013; 2013: 693486.
42. Nguyen VQ, Ishihara M, Mori Y, et al. Preparation of size-controlled silver nanoparticles and chitosan-based composites and their anti-microbial activities. Biomed Mater Eng 2013; 23: 473-483.
43. Kumar-Krishnan S, Prokhorov E, Hernández-Iturriaga M, et al. Chitosan/silver nanocomposites: synergistic antibacterial action of silver nanoparticles and silver ions. Eur Polym J 2015; 67: 242-251.
44. Said DE, Elsamad LM, Gohar YM,. Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents. Parasitol Res 2012; 111: 545-554.
45. Allahverdiyev A, Abamor ES, Bagirova M, et al. Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light. Int J Nanomedicine 2011; 6: 2705-2714.
46. Jebali A, Kazemi B,. Nano-based antileishmanial agents: a toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis. Toxicol in Vitro 2013; 27: 1896-1904.
47. Ribeiro TG, Franca JR, Fuscaldi LL, et al. An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis. Int J Nanomedicine 2014; 9: 5341-5353.
48. Ali SW, Rajendran S, Joshi M,. Synthesis and characterization of chitosan and silver loaded chitosan nanoparticles for bioactive polyester. Carbohydr Polym 2011; 83: 438-446.
49. Wong KKY, Cheung SOF, Huang L, et al. Further evidence of the anti-inflammatory effects of silver nanoparticles. ChemMed Chem 2009; 4: 1129-1135.
50. David L, Moldovan B, Vulcu A, et al. Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract. Colloids Surf B Biointerfaces 2014; 122: 767-777.
51. Franci G, Falanga A, Galdiero S, et al. Silver nanoparticles as potential antibacterial agents. Molecules 2015; 20: 8856-8874.
52. Ong SY, Wu J, Moochhala SM, et al. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials 2008; 29: 4323-4332.
53. Zeledón RA,. Hemoflagellates. In: Baron S, (ed.) Medical microbiology. University of Texas Medical Branch at Galveston, http://www.ncbi.nlm.nih.gov/pubmed/21413333 (1996,. accessed 13 September 2016).